Navigation Links
IR BioSciences Announces Data Demonstrating Radilex Stimulation of,Stem Cells Results in Hematopoietic Recovery Following Lethal,Irradiation

Animal Data Shows Prolonged Survival AND Increased Platelet Concentrations

SCOTTSDALE, Ariz., March 08, 2007 /PRNewswire-FirstCall/ -- ImmuneRegen BioSciences, a wholly-owned subsidiary of IR BioSciences Holdings, Inc. announced today that ongoing analysis of data acquired from previously performed animal efficacy studies has revealed evidence that ImmuneRegen's developmental stage product, Radilex(TM), may stimulate hematopoietic stem cells.

Studies performed at the Oak Ridge National Laboratory reveal that ImmuneRegen's potential radioprotectant product, Radilex, not only prolonged survival of animals exposed to lethal gamma irradiation, but appeared to have increased platelet concentrations in surviving animals. As the experimental protocol required these animals to be subject to repeated blood sampling as well as irradiation, saline injections were relied on for plasma volume restoration. In the face of the resulting hemodilution, compensatory hematopoietic mechanisms were nonetheless adequately stimulated to enable survival of a number of Radilex-treated, but no untreated, animals. Blood cell quantitation showed trends in the surviving animals toward neutrophil replenishment as well. ImmuneRegen has since filed a provisional patent entitled "Method to Treat Blood Cell Depletion" to provide intellectual property protection for this finding regarding Radilex.

Continuing radiation studies will be performed at both the Translational Genomics Research Institute (TGen) and TGen Drug Development Services (TD2, its drug development arm) and at the Pacific Northwest National Laboratory to further explore the impact of radiation on the hematopoietic system of Radilex-exposed animals. ImmuneRegen's ongoing studies will be designed to examine mechanistic indicators at both high levels of radiation where Radilex has shown protection, as well as at lower levels. If successful, these studies will enable Rad
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
3. Sangamo BioSciences Announces Presentation of Phase 1 ZFP Therapeutic Data at American Diabetes Association Meeting
4. IR BioSciences Announces Promising Data from Study of Its Compound Homspera
5. Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at American Society for Neural Therapy and Repair Meeting
6. YM BioSciences Reports AeroLEF Randomized Phase IIb Trial Meets Primary Endpoint in Patients with Post-Surgical Pain
7. ImmuneRegen BioSciences Announces Promising Data on Homspera Suggesting Potential as a Co-Therapeutic Agent
8. Study in Cell by Magen BioSciences Co-Founder David E. Fisher Identifies New Roles in Skin Cancer Prevention for Key Tumor Suppressor Protein
9. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
10. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
11. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
Post Your Comments:
(Date:8/30/2014)...  Boston Scientific has released the primary endpoint ... Failure (NECTAR-HF) clinical trial, the first and only ... (VNS) for the treatment of heart failure patients.  ... Cardiology and Director of the Clinical Investigation Center ... de la Recherche Medicale presented the results at ...
(Date:8/30/2014)... Mass. , Aug. 30, 2014   Royal ... of Affiniti, a new ultrasound system designed ... the demands of increasing patient volumes and cost pressures. ... Congress 2014 in Barcelona ... departments facing more patients with fewer resources deliver high ...
(Date:8/29/2014)... /PRNewswire-iReach/ -- Market Research Report on Global and ... professional and in-depth market survey on Global ... report firstly reviews the basic information of X-Ray ... technology. The report then explores global and China,s ... product specification, capacity, Production value, and market share ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
(Date:8/31/2014)... (PRWEB) August 31, 2014 Green ... harmful disc brake dust at the source while ... Problem: Millions of vehicles globally emit brake dust/debris ... in the friction materials (disc brake pads) are ... nations’ water systems. For example, copper impairs and ...
(Date:8/31/2014)... Priya Khan, Director of Research & Development at ... weight-loss supplements saying, “Consumers are understandably frustrated with ... propagated by unscrupulous companies about weight-loss products.” Even ... the subject. , NutriGold’s mission is to educate ... and to provide them with guidelines for choosing ...
(Date:8/31/2014)... August 31, 2014 To make it ... brand they can trust, NutriGold is shipping complimentary samples ... form has been set up to make taking advantage ... , According to Priya Khan, Director of Research and ... purchase one of our products, they are entrusting us ...
(Date:8/31/2014)... 2014 “Prohibition is our history,” ... our future: the present ~ that’s political.” , ... , new on the Bryan William Brickner Blog, ... system (CS) modulation and homeostasis - including one ... use. The Publius CS update includes: heteromerization ...
(Date:8/31/2014)... Top10BestSEOHosting.com has recently compared many professional web ... ), Bluehost and GoDaddy are the best hosting ... Top10BestSEOHosting.com says, “These companies have outperformed other competitors ... so that we call them the Best VPS ... get the best web hosting to enjoy the ...
Breaking Medicine News(10 mins):Health News:CBPModular Technology with Global Patent Coverage Solves Vehicle Wheel Brake Dust Problem 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 3Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Homeostasis: Publius’ Alcohol Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2Health News:Top10BestSEOHosting.com Announces The Best Hosting Suppliers In 2014: iPage, Bluehost and GoDaddy 2
... events , WEDNESDAY, May 5 (HealthDay News) -- A ... significantly cuts down on hospital drug errors, researchers from ... "We had the opportunity to design and implement a ... the hospital gets the right medication at the right ...
... those mental illnesses are still common, especially among women, survey ... report finds that older people have lower rates of mental ... the conditions remain common, especially in women. , Researchers led ... San Francisco analyzed a survey of 2,575 people aged 55 ...
... it may not help older men and women with sexual problems ... partner report greater happiness and those who talked with friends ... Journal of Gerontology: Social Sciences , shows that the way ... later years varies greatly and that there is not one solution ...
... ... Healthy CHOICES Act, and just days after the release of America’s first-ever ... and leaders from the fitness industry are gathering on Capitol Hill as ... will meet with Members of Congress to share their vision for a ...
... ... with online resources dedicated to the technical requirements associated with large format touch screens. ... particular makes this need an immediate one. See how they answered the call... ... (PRWEB) May 5, ...
... Research Institute (CRI) is participating in an international study ... and chronic lymphocytic leukemia. "This study is important ... to treat patients with leukemia or lymphoma," said Arthur ... Research Institute, and principal investigator for the Temple portion ...
Cached Medicine News:Health News:Bar Codes Cut Down on Hospital Medication Errors 2Health News:Bar Codes Cut Down on Hospital Medication Errors 3Health News:Friendship and confiding in spouse eases stress over sexual issues in older men 2Health News:Friendship and confiding in spouse eases stress over sexual issues in older men 3Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 2Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 3Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 4Health News:Fitness Industry Gathers on Capitol Hill Hours After Healthy CHOICES Act is Introduced, Urging Congress to Pass Anti-Obesity, Exercise Promotion Legislation 5Health News:Horizon Display Demonstrates their Dedication to After-Sales Support with Enhanced Online Resources 2Health News:Horizon Display Demonstrates their Dedication to After-Sales Support with Enhanced Online Resources 3Health News:Scott & White Healthcare clinical trials target lymphoma, leukemia 2
A One Piece Support Garment - any length or size...
Body Suit w/Bra torso...
Male Compression Vest Binder...
Ideal for breast compression with adjustable hook and eye closure....
Medicine Products: